US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
NYSE
Bio Rad Laboratories Inc (BIO.B)
Bio Rad Laboratories Inc (BIO.B) ニュース

Bio Rad Laboratories Inc (BIO.B)

296.49

0.00

(0.00%)

終了 7月7日 5:00AM

0.00

0.00

(0.00%)

取引時間後: 5:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 144 - Report of proposed sale of securities

Form SD - Specialized disclosure report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Bio-Rad to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bio-Rad Reports First-Quarter 2026 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

someguy41

someguy41 7分前

Its just market makers or some BS. This thing is trash its always been trash and any of us that got suckered into investing deserve this. There's nothing here its a shell game and we're all bag holding idiots.

INEEDMONEY

INEEDMONEY 7分前

I guess this will never move!! Good job Logan.

JCESOSA

JCESOSA 8分前

rosemountbomber

rosemountbomber 9分前

CRNX another good example of a buyout before phase 3 results of their lead candidate.

HyGro

Sorry, deniers need facts not just their rabid opinions.

stockanalyze

stockanalyze 12分前

naked short selling must stop. file compliant with sec . i have had no luck with sec filing complaints ever but may be you will. this is real, naked short selling going on and large banks making a ton and manipulating. not uplisting is like promoting such fraud. no reason not to, a low hanging fruit

DrivenByPain

DrivenByPain 12分前

Executing the Strategy🤑

Execution remained the defining theme throughout the second quarter as Suntex continued strengthening its diversified operating platform across its seven wholly owned subsidiaries serving construction, electrical contracting, infrastructure, land develo

HyGro

Sorry, deniers need facts not just their rabid opinions.

HyGro

We're talking about OTC. NASDAQ already pushed NWBO out.

MRJ25

One of these days you will be right.

HyGro

Clearly no "valid clinical design" as FDA wasn't buying it. Just watch, NWBO won't apply for U.S. approval until they do another trial. P3 trial was manipulated.

jcromeenes

jcromeenes 18分前

I remember about 10 years ago there was a job posting for a job relating to stock market compliance, don't remember the title exactly, and we all got excited. Well, 10 years has passed.

JP313

Get money my g Im pulling for you, I hope this gem of gems come through for you.

US Market News

US Market News 23分前

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2026July 6, 2026 9:57 PM
Business WireMitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it

northam43

northam43 27分前

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

northam43

northam43 28分前

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

Lewrock

Lewrock 31分前

It is a good position to be in from a cost standpoint. The key to maximizing our gross margin is to articulate our value proposition on a total cost of ownership basis vs our incumbent competition. We don’t need to dramatically undercut the competition. If our power savings saves the customer $10, t

Hey_Its_That_Guy

Hey_Its_That_Guy 32分前

Lawyers for large companies happen all the time regular sop

jhdf51

jhdf51 33分前

Meanwhile I really like the future of this company.

JHD

Monroe1

Monroe1 34分前

Percentage of Shares Shorted
2.73% of the float of CytoDyn has been sold short.
Short Interest Ratio / Days to Cover
CytoDyn has a short interest ratio ("days to cover") of 12.25

Everyone save back a little extra cash and pile on for the moment the news hits that

DrHigh

DrHigh 37分前

Str8t-talk

Str8t-talk 39分前

Be sure to mention to Moss if you’re a shareholder.

jammy32

jammy32 45分前

82 cents to 36 cents.

CrapIsCrap

CrapIsCrap 46分前

Probably because 95% of all press releases are BS. Fahman has never produced anything other than shares to sell.

Bio Rad Laboratories

2.75% 17aug2046

Bnp 0.07% until 20/05/30...

Arrcus Share Class Level...

Woodside Energy (PK)

Detroit Legal News (PK)

Economic Master Issuer

American Acquisition Opp...

Ambrx Biopharma

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。